Floatz logo

12 assets in Intraocular Lymphoma

Therapeutic assets addressing Intraocular Lymphoma, rated under Floatz methodology v0.2 and sorted by current rating.

AssetSponsorPhaseRating
Cyclophosphamide
Intraocular Lymphoma
Peking Union Medical College HospitalP2BBB (72)
Rituximab
Intraocular Lymphoma
Peking Union Medical College HospitalP2BBB (72)
Adriamycin
Intraocular Lymphoma
Peking Union Medical College HospitalP2BB (66)
Prednisone
Intraocular Lymphoma
Peking Union Medical College HospitalP2BB (66)
Vincristine Sulfate
Intraocular Lymphoma
Peking Union Medical College HospitalP2BB (64)
Methotrexate
Intraocular Lymphoma
Aldeyra Therapeutics, Inc.P3B (63)
Zanubrutinib
Intraocular Lymphoma
Peking Union Medical College HospitalP2CCC (53)
Autologous Cd19Car-Cd28-Cd3Zeta-Egfrt-Expressing Tcm-Enriched T Cells
Intraocular Lymphoma
City of Hope Medical CenterP1CC (43)
Icm Adx-2191
Intraocular Lymphoma
Aldeyra Therapeutics, Inc.P3NR ()